@immunesk.com
Developing Novel Drugs for Malignant and Auto-Immune Diseases
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Immune System Key Ltd. (ISK) is a pioneering company focused on the development of revolutionary treatments for malignant and autoimmune diseases. Founded in 2005 by Prof.
Uziel Sandler and Dr. Yoram Devary, ISK utilizes innovative human secreted peptides, discovered by its founders, as the foundation for its groundbreaking therapies. The company's lead compound, Nerofe TM, has received orphan drug status from the FDA for the treatment of AML and is currently in the phase IIa development stage.
ISK holds three global patents for this molecule and its applications. ISK continues to make significant strides in the field of medical research. Recently, the company received FDA approval for its second clinical trial, focusing on patients with pancreatic cancer and metastatic colorectal cancer.
This trial is being conducted at Georgetown University in Washington, D. C. By pushing the boundaries of science and research, ISK is dedicated to transforming the landscape of healthcare and providing hope for patients with unmet medical needs.
To learn more about their breakthroughs and advancements, visit their website or contact them directly
Company Type
Privately Held
Company Size
2-10
Year Founded
2006
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories